Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 10, 2022

SELL
$1.09 - $1.67 $333,319 - $510,682
-305,798 Reduced 3.45%
8,547,965 $9.32 Million
Q2 2022

Aug 12, 2022

BUY
$1.13 - $3.69 $4.45 Million - $14.5 Million
3,941,049 Added 80.22%
8,853,763 $13.2 Million
Q1 2022

May 16, 2022

BUY
$2.85 - $3.73 $14 Million - $18.3 Million
4,912,714 New
4,912,714 $16.2 Million
Q2 2020

Aug 13, 2020

SELL
$4.78 - $8.26 $6.28 Million - $10.8 Million
-1,313,100 Closed
0 $0
Q1 2020

May 14, 2020

SELL
$4.0 - $21.53 $952,800 - $5.13 Million
-238,200 Reduced 15.35%
1,313,100 $5.25 Million
Q4 2019

Feb 13, 2020

BUY
$13.94 - $24.12 $4.35 Million - $7.52 Million
311,732 Added 25.15%
1,551,300 $33.3 Million
Q3 2019

Nov 13, 2019

BUY
$13.89 - $23.16 $4.29 Million - $7.16 Million
308,964 Added 33.2%
1,239,568 $18.8 Million
Q2 2019

Aug 13, 2019

SELL
$16.27 - $20.51 $256,659 - $323,545
-15,775 Reduced 1.67%
930,604 $18 Million
Q1 2019

May 14, 2019

SELL
$12.61 - $22.33 $1.94 Million - $3.43 Million
-153,621 Reduced 13.97%
946,379 $19.6 Million
Q4 2018

Feb 13, 2019

SELL
$12.41 - $22.98 $4.96 Million - $9.19 Million
-400,000 Reduced 26.67%
1,100,000 $15 Million
Q3 2018

Nov 28, 2018

BUY
$2.45 - $16.27 $905,108 - $6.01 Million
369,432 Added 32.68%
1,500,000 $24.4 Million
Q3 2018

Nov 13, 2018

SELL
$2.45 - $16.27 $11.1 Million - $73.9 Million
-4,539,637 Reduced 80.06%
1,130,568 $18.4 Million
Q2 2018

Aug 14, 2018

SELL
$2.68 - $3.48 $244,887 - $317,988
-91,376 Reduced 1.59%
5,670,205 $17.5 Million
Q1 2018

May 14, 2018

BUY
$2.99 - $4.44 $17.2 Million - $25.5 Million
5,744,048 Added 32761.35%
5,761,581 $17.3 Million
Q4 2017

Feb 13, 2018

BUY
$3.06 - $4.09 $53,650 - $71,709
17,533 New
17,533 $70,000
Q3 2017

Nov 13, 2017

SELL
$3.03 - $3.72 $227,249 - $279,000
-75,000 Closed
0 $0
Q2 2017

Aug 14, 2017

BUY
N/A
75,000
75,000 $302,000

Others Institutions Holding AMRN

About AMARIN CORP PLCUK


  • Ticker AMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 403,206,016
  • Market Cap $222M
  • Description
  • Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...
More about AMRN
Track This Portfolio

Track Stonepine Capital Management, LLC Portfolio

Follow Stonepine Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stonepine Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stonepine Capital Management, LLC with notifications on news.